ClinicalTrials.govpublic full text
Efficacy and Safety Study of bb2121 in Subjects With Relapsed and Refractory Multiple Myeloma
multiple myeloma, efficacy and safety, bb2121, car t cell, bcma, relapsed and refractory, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 865065
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.